We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
-0.8%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+359.15%
AUM
$40.5B
AUM Growth
-$1.74B
Cap. Flow
-$1.03B
Cap. Flow %
-2.55%
Top 10 Hldgs %
7.42%
Holding
3,192
New
162
Increased
1,347
Reduced
1,471
Closed
153

Sector Composition

Rank Sector Weight
1 Healthcare 13.53%
2 Technology 11.68%
3 Financials 10.76%
4 Consumer Discretionary 10.34%
5 Industrials 8.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FICO icon
851
Fair Isaac
FICO
$24.3B
$9.55M 0.02%
105,236
+583
+0.6% +$52.3K
EVHC
852
DELISTED
Envision Healthcare Holdings Inc
EVHC
$9.55M 0.02%
80,792
-7,376
-8% -$839K
BPL
853
DELISTED
Buckeye Partners, L.P.
BPL
$9.55M 0.02%
129,108
+18,585
+17% +$1.46M
ISD
854
PGIM High Yield Bond Fund
ISD
$415M
$9.54M 0.02%
616,886
-56,109
-8% -$894K
EFR
855
Eaton Vance Senior Floating-Rate Fund
EFR
$312M
$9.52M 0.02%
692,518
+50,129
+8% +$724K
NAC icon
856
Nuveen California Quality Municipal Income Fund
NAC
$1.83B
$9.49M 0.02%
660,213
-139,215
-17% -$2.1M
AEGN
857
DELISTED
Aegion Corp
AEGN
$9.48M 0.02%
500,460
-464,216
-48% -$8.54M
SKX
858
DELISTED
Skechers
SKX
$9.48M 0.02%
258,993
+114,294
+79% +$3.67M
NS
859
DELISTED
NuStar Energy L.P.
NS
$9.46M 0.02%
159,397
-107,401
-40% -$6.79M
VGR
860
DELISTED
Vector Group Ltd.
VGR
$9.45M 0.02%
725,245
+46,141
+7% +$574K
NKTR icon
861
Nektar Therapeutics
NKTR
$2.39B
$9.42M 0.02%
50,215
+22,335
+80% +$3.84M
ANAC
862
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
$9.41M 0.02%
121,596
+3,604
+3% +$236K
WNR
863
DELISTED
Western Refining Inc
WNR
$9.38M 0.02%
215,003
-24,175
-10% -$1.07M
TSLA icon
864
Tesla
TSLA
$1.23T
$9.35M 0.02%
522,720
-241,335
-32% -$3.82M
PAA icon
865
Plains All American Pipeline
PAA
$17.3B
$9.32M 0.02%
214,033
+62,713
+41% +$3.01M
SEDG icon
866
SolarEdge
SEDG
$2.51B
$9.32M 0.02%
+256,493
New +$8.26M
BC icon
867
Brunswick
BC
$5.13B
$9.31M 0.02%
183,049
-2,983
-2% -$156K
EFT
868
Eaton Vance Floating-Rate Income Trust
EFT
$283M
$9.27M 0.02%
672,359
+144,059
+27% +$2.09M
NOK icon
869
Nokia
NOK
$51B
$9.25M 0.02%
1,350,425
+1,258,505
+1,369% +$9.17M
UAL icon
870
United Airlines
UAL
$39.4B
$9.24M 0.02%
174,390
-70,633
-29% -$4.09M
IPI icon
871
Intrepid Potash
IPI
$456M
$9.22M 0.02%
77,222
-42,477
-35% -$5.03M
CLVS
872
DELISTED
Clovis Oncology, Inc.
CLVS
$9.18M 0.02%
104,476
+6,585
+7% +$564K
CLDT
873
Chatham Lodging
CLDT
$622M
$9.17M 0.02%
346,605
-129,159
-27% -$3.64M
MDU icon
874
MDU Resources
MDU
$4.17B
$9.13M 0.02%
1,229,881
-803,683
-40% -$6.46M
HTS
875
DELISTED
HATTERAS FINANCIAL CORP
HTS
$9.13M 0.02%
560,436
-101,243
-15% -$1.82M

Similar funds

Guggenheim Capital's Q2 2015 Portfolio in Review

As of Q2 2015, Guggenheim Capital held 3,192 positions worth $40.5B, down 4.1% from $42.2B the previous quarter. Its ten largest holdings account for 7.4% of the portfolio.

Guggenheim Capital's Q2 2015 filing shows 162 new, 1,347 increased, 1,471 reduced and 153 closed positions. Its largest new stake was State Street SPDR Dow Jones Industrial Average ETF Trust: 158,500 shares worth $27.9M. The largest sale was Covanta Holding Corporation, an estimated $71.6M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 12% a quarter earlier, followed by Technology and Financials.

  • Guggenheim Capital's largest Q2 2015 buy was State Street SPDR Dow Jones Industrial Average ETF Trust: 158,500 shares worth $27.9M.
  • Guggenheim Capital added most to Qorvo in Q2 2015, an estimated $45.3M increase.
  • Guggenheim Capital's biggest Q2 2015 reduction was Covanta Holding Corporation, cutting an estimated $71.6M.
  • Guggenheim Capital fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $66M.
  • Guggenheim Capital's ten largest holdings make up 7.4% of its $40.5B portfolio in Q2 2015.
  • Guggenheim Capital opened 162 new positions and closed 153 in Q2 2015.
  • Guggenheim Capital's portfolio value fell 4.1% quarter-over-quarter to $40.5B.

Based on Guggenheim Capital's 13F filing for Q2 2015, filed 14 Aug 2015.